Association of High Tumor Mutation Burden in Non-Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels (vol 8, pg 1160, 2022)

被引：0
|
作者：
Ricciuti, B.
Wang, X.
Alessi, J., V
机构：
来源：
JAMA ONCOLOGY | 2022年 / 8卷 / 11期
关键词：
D O I：
10.1001/jamaoncol.2022.5957
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1702 / 1702
页数：1
相关论文
共 50 条
  • [11] Tumor Mutation Burden as a Potential Biomarker for PD-1/PD-L1 Inhibition in Advanced Non-small Cell Lung Cancer
    Di Huang
    Fan Zhang
    Haitao Tao
    Sujie Zhang
    Junxun Ma
    Jinliang Wang
    Zhefeng Liu
    Pengfei Cui
    Shixue Chen
    Ziwei Huang
    Zhaozhen Wu
    Lei Zhao
    Yi Hu
    [J]. Targeted Oncology, 2020, 15 : 93 - 100
  • [12] Tumor Mutation Burden as a Potential Biomarker for PD-1/PD-L1 Inhibition in Advanced Non-small Cell Lung Cancer
    Huang, Di
    Zhang, Fan
    Tao, Haitao
    Zhang, Sujie
    Ma, Junxun
    Wang, Jinliang
    Liu, Zhefeng
    Cui, Pengfei
    Chen, Shixue
    Huang, Ziwei
    Wu, Zhaozhen
    Zhao, Lei
    Hu, Yi
    [J]. TARGETED ONCOLOGY, 2020, 15 (01) : 93 - 100
  • [13] Spatial heterogeneity of PD-L1 expression and the risk for misclassification of PD-L1 immunohistochemistry in non-small cell lung cancer
    Dori, Shani Ben
    Aizic, Asaf
    Sabo, Edmond
    Hershkovitz, Dov
    [J]. LUNG CANCER, 2020, 147 : 91 - 98
  • [14] Meta-Analysis of Circulating Tumor Cell PD-L1 Expression and the Association with Clinical Outcomes in Non-Small Cell Lung Cancer
    Acheampong, Emmanuel
    Allsopp, Rebecca C.
    Page, Karen
    Wadsley, Marc K.
    Beasley, Aaron B.
    Coombes, R. Charles
    Shaw, Jacqui A.
    Gray, Elin S.
    [J]. CLINICAL CHEMISTRY, 2024, 70 (01) : 234 - 249
  • [15] Tumor Mutational Burden as a Potential Predictive Biomarker of Response to PD-1/PD-L1 Blockade in Non-Small Cell Lung Cancer
    Kim, H.
    Kwon, H. J. K.
    Kim, E. S. K.
    Han, Y. B.
    Lee, J.
    Kim, S. H.
    Kim, Y. J.
    Lee, J.
    Chung, J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S470 - S470
  • [16] Quantification of PD-L1 expression in non-small cell lung cancer
    Verma, Vivek
    Chang, Joe Y.
    [J]. TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S402 - S404
  • [17] PD-L1 expression testing in non-small cell lung cancer
    Teixido, Cristina
    Vilarino, Noelia
    Reyes, Roxana
    Reguart, Noemi
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2018, 10
  • [18] Gene expression profile of high PD-L1 non-small cell lung cancers refractory to pembrolizumab
    Jamila Talb
    Paul Takam Kamga
    Marie Mayenga
    Adrien Costantini
    Catherine Julié
    Coraline Dumenil
    Jennifer Dumoulin
    Julia Ouaknine
    Violaine Giraud
    Cécile Dujon
    Reza Azarian
    Claire Glaser
    Jean-François Emile
    Etienne Giroux Leprieur
    [J]. Cancer Immunology, Immunotherapy, 2022, 71 : 2791 - 2799
  • [19] PD-L1 Expression in Patients with Non-small Cell Lung Cancer
    Masago, Katsuhiro
    Fujita, Shiro
    Hata, Akito
    Okuda, Chiyuki
    Kaji, Reiko
    Katakami, Nobuyuki
    Hirata, Yukio
    [J]. ANTICANCER RESEARCH, 2017, 37 (05) : 2269 - 2274
  • [20] Gene expression profile of high PD-L1 non-small cell lung cancers refractory to pembrolizumab
    Talb, Jamila
    Kamga, Paul Takam
    Mayenga, Marie
    Costantini, Adrien
    Julie, Catherine
    Dumenil, Coraline
    Dumoulin, Jennifer
    Ouaknine, Julia
    Giraud, Violaine
    Dujon, Cecile
    Azarian, Reza
    Glaser, Claire
    Emile, Jean-Francois
    Leprieur, Etienne Giroux
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (11) : 2791 - 2799
12345